Skip to main content
OpenTrials
Completed

NCT Number: NCT05721092

Assessment of Knowledge on Pneumococcal Vaccination Among Diabetologists in India

Asia has the highest burden with the largest contribution of pneumonia burden from India. Pneumonia is also observed as 5th leading cause of deaths in India. People with diabetes with uncontrolled glucose are significantly at higher risk of development of pneumonia. Even though, pneumonia is a vaccine-preventable disease, hospitalization for pneumonia of patients with diabetes are rising. Very limited literature is available on the knowledge and practice of pneumonia vaccination among diabetologists and the rate of pneumonia vaccination received by the patients with diabetes. Hence this study aims to assess their knowledge on the same. In addition, this study also aims to identify the real barriers and facilitators of pneumococcal vaccination among diabetologists in India. A cross-sectional study will be conducted among 25diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.

Completed

Looking for future studies?

Notify Me

Key information

Age range

25 year–65 year

Sex eligibility

All sexes

Study type

Observational

Primary location

M V Hospital for Diabetes [P] Limited

Chennai, Tamil Nadu, 600013, India

Who can participate

Healthy volunteers accepted: Yes

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

Diabetologists willing to participate in the study

Exclusion criteria

Unwillingness to give consent for participation

Treatment and study plan

Pre and Post Education on practice of pneumococcal vaccination

Other

A cross-sectional study will be conducted among 25 diabetologists in each of the four zones in India representing all directions - North, East, West and South. Diabetologists will be selected through purposive sampling. A semi-structured questionnaire (study tool) is designed based on the existing literature that addresses our objectives. An education session on Pneumococcal vaccination will be conducted for the diabetologists through webinar after completing the survey. A post assessment will be done using the same questionnaire among the study participants after the education session in order to see an increase in the knowledge of pneumococcal vaccination.

Primary outcomes

  1. To identify the facilitators and barriers of pneumococcal vaccination among diabetologists in India.

    Time frame: 6 months

Secondary outcomes

  1. To assess the knowledge, attitude and practices of pneumococcal vaccination among select diabetologists across India.

    Time frame: 6 months

  2. To examine the association of knowledge and practice of vaccination among diabetologists

    Time frame: 6 months

  3. To assess the change in the knowledge of pneumococcal vaccination post educational intervention

    Time frame: 6 months

Sponsors and collaborators

Lead sponsor

M.V. Hospital for Diabetes

Other

Collaborators

  • MSD Pharmaceuticals LLC

Registry information

Official study title

Assessment of Knowledge, Facilitators and Barriers of Pneumococcal Vaccination: A Cross-sectional Study Among Diabetologists in India

Important dates

Study start
2023
Primary completion
2024
Study completion
2024
First posted
Feb 9, 2023
Registry last updated
Mar 25, 2024

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.